Archives

David Cameron Martine Piccart Eric Van Cutsem Jim Cassidy Volker Heinemann Lapatinib Better for Patients with HER2+ Refractory Breast Cancer Pre-treated with Chemotherapy and Trastuzumab REFERENCE: ES

Gordon McVie Martine Piccart Bella Kaufman Jean-Yves Douillard ESMO Congress Reviewed GORDON MCVIE, European Institute of Oncology, Milan In Istanbul, Gordon McVie gave his opinion about the achieveme

CHRISTIAN SPAULDING, Cochin Hospital, Paris REFERENCE: N Engl J Med 2006;355:1093, 1105,1169 Two leading articles in the same edition of the New England Journal of Medicine have investigated the use o

&t Jonathan Li

Bart Rijnders J. Owen Hendley Philippe Colucci Inhalation Therapy Can Prevent Invasive Aspergillosis REFERENCE: Abstract M-1308c Bart Rijnders, University Hospital, Rotterdam Patients undergoing chemo

George Canellos Sandra Strauss Nancy Baxter KIT Mutations in Acute Myeloid Leukemia Confer Higher Relapse Risk Liver Metastasis Resection Not Curative for Colorectal Cancer Patients With Node Negative

Jose Miro Julia Dombrowski Graeme Forrest HIV/AIDS Antiretroviral Therapy: Good to Start when CD4 Count Drops Below 350 REFERENCE: Abstract H-1059 Jose Miro, Hospital Clinic, Barcelona When is the bes

MICHAEL MARMOT, University College, London REFERENCE: Lancet, 2006; 364:367 and 341 A study published in the Lancet from the University of Toronto concludes that half of the mortality differences betw

Henry Fraimow Michael Jacobs Ron Dagan MRSA: Not Only Carried in the Nose REFERENCE: Abstract C2-605 Henry Fraimow, Cooper University Hospital, Camden, New Jersey Methicillin resistant Staphylococcus

CHARLES HICKS, Associate Professor Medicine, Duke University, Durham REFERENCE: Lancet 2006; 368: 466-75 Results with a new antiretroviral agent, tipranavir, tested among patients who were resistant t

Roger Baxter Jaap van Dissel Which Antibiotics Pose Greatest Risk of C. difficile infection? REFERENCE: Abstract K-0349 Roger Baxter, Kaiser Permanente, Oakland In the presence of certain antibiotics,

PAUL NEWTON, Centre for Clinical Vaccinology and Tropical Medicine, Oxford REFERENCE: Lancet Infect Dis 2006; 6:602-13 No one knows the exact proportion of anti-infective drugs in the developing world

Robert Ozols William See Ruth Lupu Improving on Standard Treatment in Ovarian Cancer: Have We Hit a Wall? REFERENCE: Abstract 5002, 2006 ASCO Annual Meeting; N Engl J Med 2006, 354:34-43 ROBERT OZOLS,

Andrew Pipe Bryan Williams STOP – Smoking The Opinions of Physicians, A Global Survey REFERENCE: European Society of Cardiology Meeting with the World Congress of Cardiology, Barcelona, Septembe

Thomas Gaziano, Brigham & Womens’ Hospital, Boston REFERENCE: Lancet 2006; 368: 679-86 Heart disease is currently the leading cause of death in less developed nations but it can be prevented

Christoph Kaiser John Cleland BASKET Study Shows Bare Metal Stents Can Be Better REFERENCE: 4825 “Clinical Trial Update I” Session Christoph Kaiser, University of Basel Bare metal stents m

Gilles Montalescot Freek Verheugt Angioplasty: Four-Continent RIVIERA Study Identifies “Real World” Modifiable Factors Which Affect Outcome REFERENCE: Abstract 3413, “Hot Line II&rdq

REFERENCE: Abstract 1011 to 1016 Tony Gershlick, Leicester University A session entitled: “Stent Thrombosis in the Drug-Eluting Stents Era” at the Barcelona congress identified important m

Shamir Mehta Keith Fox Petr Widimsky Gerrit Veen OASIS 5 & 6: Fondaparinux Anticoagulation: Benefit on Mortality, Events and Bleeding in Acute Coronary Syndromes and ST-Elevation Myocardial Infarc

David Wood Magnus Ohman Kenneth Morgan Philip Poole-Wilson EUROACTION Study: Nurse-Led Teams Succeed in Modifying Lifestyle to Reduce Coronary Risks REFERENCE: Abstract 986; Hot Line 1 Session David W

Anthony Wierzbicki Gabriel Steg David Paquette Add HDL-Raising Therapy to Maximise Lipid Treatment REFERENCE: Abstract 53, Page 85 Anthony Wierzbicki, St Thomas’s Hospital, London The idea of ad

Jeremiah Ngondi, Cambridge University REFERENCE: Lancet 2006; 368: 589-95 A new investigation shows that trachoma (and resulting blindness) can be prevented by the World Health Organisation’s SA

Mark Socinski Bruce Johnson Neil Shah Doug Smith Sunitinib Multi-Targeted Oral Anti-Angiogenic Therapy Responses in Lung Cancer REFERENCE: Abstract 7001 Mark A. Socinski, Univerisity of North Carolina

Miia Kivipelto, Karolinska Institute, Stockholm REFERENCE: Lancet Neurology On Line: August 3rd, 2006 A 20 year study in Finland has identified important risk factors for dementia. Investigator

Joan Houghton Elizabeth Barrett-Connor Fran Balkwill Carl Christophe Schimanski Adjuvant Anastrozole for Patients With Breast Cancer: Long-Term Safety Results From the ATAC Study REFERENCE: Lancet Onc